Study Backs Minimally Invasive Aortic Stenosis Treatment
Study Backs Minimally Invasive Aortic Stenosis Treatment In a groundbreaking international multicenter study, patients with a dysfunctional aortic heart valve who received a prosthetic valve through a minimally invasive procedure experienced similar outcomes at the five-year mark to those who underwent traditional open-heart surgery. The study, with significant contributions from the Cedars-Sinai heart team and recently published in The New England Journal of Medicine, sheds fresh light on the ongoing debate surrounding the efficacy of transcatheter aortic valve replacement (TAVR) as compared to open-heart surgery. Dr. Raj Makkar, the senior author of the study and Cedars-Sinai’s Vice President of Cardiovascular Innovation and Intervention, as well as the Associate Director of the Smidt Heart Institute, emphasized the significance of the findings. “Our data at five years validate that TAVR is a good alternative to open-heart surgery in younger patients with aortic stenosis,” he stated....